desk
Share
News Topical, Digital Desk : The IPO of Shringar House of Mangalsutra has opened today, 10 September 2025. This company makes mangalsutras for many big companies in the jewelry industry. The price band of this ₹401 crore IPO has been fixed at ₹155 to ₹165 per share, in which one lot is of 90 shares. The minimum investment is ₹14,850.
Ahead of the IPO, the company has raised ₹120.19 crore from anchor investors, including institutions such as Kotak Mahindra Life Insurance, Maybank Securities, Societe Generale, Plutus Investment Trust, North Star Opportunities Fund, Founders Collective, Mint Focused Growth Fund, Aidos India Fund, Rajasthan Global Securities, Sunrise Investment Trust, Astrone Capital, Jalan Chemical Industries, Shine Star Build and NAV Capital. The premium for the IPO in the grey market has reached 18%, indicating sharp listing gains.
Brokerages, SBI Securities and Anand Rathi, are recommending to subscribe to this IPO. The company has recorded consistent earnings growth over the years. It is currently setting up a supply chain model in 42 cities across India. The company's business is working capital intensive as it buys gold on immediate payment, while giving customers a credit period of 15-20 days. It is likely to benefit from the growing shift to the organised sector and the large market for mangalsutra. How does the company work? Shringar House of Mangalsutra designs, manufactures and markets 18-carat and 22-carat gold mangalsutras using American diamonds, pearls and semi-precious stones. Its major clients are companies like Malabar Gold, Titan, Reliance Retail, Joyalukkas, and UAE's Damas Jewellery. The IPO allotment process will be completed on September 15, and the shares will be listed on BSE and NSE on September 17. The company will use the Rs 280 crore raised from the IPO for its working capital, the rest will be spent on corporate needs. This IPO can give good rewards for investors in the long term, especially for those who want to invest in the jewellery industry.
--Advertisement--
